Literature DB >> 33241424

Avapritinib for Cutaneous Mastocytosis.

Hannah Lee1, Tian Li, Joshua Wisell, Jeffrey Schowinsky, William A Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33241424      PMCID： PMC9309867          DOI： 10.2340/00015555-3709

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  5 in total

1.  The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.

Authors:  Philipp Erben; Juliana Schwaab; Georgia Metzgeroth; Hans-Peter Horny; Mohamad Jawhar; Karl Sotlar; Alice Fabarius; Martina Teichmann; Sven Schneider; Thomas Ernst; Martin C Müller; Michelle Giehl; Alexander Marx; Karin Hartmann; Andreas Hochhaus; Wolf-Karsten Hofmann; Nicholas C P Cross; Andreas Reiter
Journal:  Ann Hematol       Date:  2013-11-27       Impact factor: 3.673

2.  Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.

Authors:  Maella Severino; Marie-Olivia Chandesris; Stéphane Barete; Emilie Tournier; Béatrix Sans; Camille Laurent; Pol André Apoil; Laurence Lamant; Claire Mailhol; Michel Laroche; Sylvie Fraitag; Katia Hanssens; Patrice Dubreuil; Olivier Hermine; Carle Paul; Cristina Bulai Livideanu
Journal:  J Am Acad Dermatol       Date:  2016-02-19       Impact factor: 11.527

3.  A precision therapy against cancers driven by KIT/PDGFRA mutations.

Authors:  Erica K Evans; Alexandra K Gardino; Joseph L Kim; Brian L Hodous; Adam Shutes; Alison Davis; Xing Julia Zhu; Oleg Schmidt-Kittler; Doug Wilson; Kevin Wilson; Lucian DiPietro; Yulian Zhang; Natasja Brooijmans; Timothy P LaBranche; Agnieszka Wozniak; Yemarshet K Gebreyohannes; Patrick Schöffski; Michael C Heinrich; Daniel J DeAngelo; Stephen Miller; Beni Wolf; Nancy Kohl; Timothy Guzi; Nicholas Lydon; Andy Boral; Christoph Lengauer
Journal:  Sci Transl Med       Date:  2017-11-01       Impact factor: 17.956

Review 4.  Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.

Authors:  Peter Valent; Cem Akin; Dean D Metcalfe
Journal:  Blood       Date:  2016-12-28       Impact factor: 22.113

5.  Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.

Authors:  Michael C Heinrich; Robin L Jones; Margaret von Mehren; Patrick Schöffski; César Serrano; Yoon-Koo Kang; Philippe A Cassier; Olivier Mir; Ferry Eskens; William D Tap; Piotr Rutkowski; Sant P Chawla; Jonathan Trent; Meera Tugnait; Erica K Evans; Tamieka Lauz; Teresa Zhou; Maria Roche; Beni B Wolf; Sebastian Bauer; Suzanne George
Journal:  Lancet Oncol       Date:  2020-07       Impact factor: 41.316
  5 in total
  1 in total

Review 1.  Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.

Authors:  Clayton Webster Jackson; Cristina Marie Pratt; Chase Preston Rupprecht; Debendra Pattanaik; Guha Krishnaswamy
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.